Abstract
The relationship between central nervous system demyelinating disorders (CNSDDs) and anti-neural antibodies (Abs), with the exception of anti-aquaporin 4 (AQP4) Abs, is not well understood. We previously screened for a variety of anti-neural Abs in the sera of Japanese patients with CNSDDs and found three patients with anti-N-methyl-d-aspartate receptor (NMDAR) Abs and three patients with anti-contactin-associated protein 2 (CASPR2) Abs. These Abs have not yet been considered as causing CNSDDs. Here, we describe CNSDD patients with these autoantibodies and discuss whether these Abs are pathogenic or not, based on the clinical presentation and literature documentation. Moreover, we propose points to which attention should be paid when dealing with patients with CNSDDs in a clinical setting.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
